HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting

Detalles Bibliográficos
Autores principales: Devine, F., Clary, A., Liu, J.H., Wu, Y.C., Park, J., Bhat, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256489/
http://dx.doi.org/10.1016/j.jval.2023.03.1404
_version_ 1785057114928971776
author Devine, F.
Clary, A.
Liu, J.H.
Wu, Y.C.
Park, J.
Bhat, A.
author_facet Devine, F.
Clary, A.
Liu, J.H.
Wu, Y.C.
Park, J.
Bhat, A.
author_sort Devine, F.
collection PubMed
description
format Online
Article
Text
id pubmed-10256489
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102564892023-06-12 HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting Devine, F. Clary, A. Liu, J.H. Wu, Y.C. Park, J. Bhat, A. Value Health Article Elsevier 2023-06 2023-06-10 /pmc/articles/PMC10256489/ http://dx.doi.org/10.1016/j.jval.2023.03.1404 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Devine, F.
Clary, A.
Liu, J.H.
Wu, Y.C.
Park, J.
Bhat, A.
HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting
title HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting
title_full HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting
title_fullStr HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting
title_full_unstemmed HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting
title_short HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting
title_sort hsd97 treatment utilization and key characteristics of covid-19 patients treated with monoclonal antibody therapy in the outpatient setting
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256489/
http://dx.doi.org/10.1016/j.jval.2023.03.1404
work_keys_str_mv AT devinef hsd97treatmentutilizationandkeycharacteristicsofcovid19patientstreatedwithmonoclonalantibodytherapyintheoutpatientsetting
AT clarya hsd97treatmentutilizationandkeycharacteristicsofcovid19patientstreatedwithmonoclonalantibodytherapyintheoutpatientsetting
AT liujh hsd97treatmentutilizationandkeycharacteristicsofcovid19patientstreatedwithmonoclonalantibodytherapyintheoutpatientsetting
AT wuyc hsd97treatmentutilizationandkeycharacteristicsofcovid19patientstreatedwithmonoclonalantibodytherapyintheoutpatientsetting
AT parkj hsd97treatmentutilizationandkeycharacteristicsofcovid19patientstreatedwithmonoclonalantibodytherapyintheoutpatientsetting
AT bhata hsd97treatmentutilizationandkeycharacteristicsofcovid19patientstreatedwithmonoclonalantibodytherapyintheoutpatientsetting

Ejemplares similares